DJ MARKET TALK: Roche Drug Herceptin Market Seen Widening

10/13/06 - Dow Jones Newswires

0617 GMT [Dow Jones] Roche (RHHBY) is asking for wider approval in the EU for its breast cancer drug Herceptin. Once approval has been granted, Roche will be allowed to sell the drug in combination with hormonal therapy. "This could add several hundreds of millions in annual sales," says Denise Anderson, analyst at Kepler Equities. Rates at buy. Roche closed at CHF221.50. (AAG)

 
Contact us in London. +44-20-7842-9464 
Markettalk.eu@dowjones.com 
 
 

(END) Dow Jones Newswires

October 13, 2006 02:17 ET (06:17 GMT)

Copyright (c) 2006 Dow Jones & Company, Inc.